If you've been on doxycycline, minocycline, clindamycin, or a rotating cast of oral antibiotics for acne, hidradenitis suppurativa (HS), rosacea, psoriasis, folliculitis, or an inflammatory skin issue that never got a clean diagnosis, and your skin still isn't clear, you're not imagining it. Antibiotics fail a meaningful share of the patients who take them for chronic skin conditions, and there are specific, measurable reasons why.

Why Your Antibiotic Might Not Be Working

Antibiotic resistance is common, and it's rising. A 2025 systematic review and meta-analysis in Frontiers in Microbiology pooled data from thousands of Cutibacterium acnes isolates worldwide and found resistance rates as high as 48% for some commonly prescribed antibiotics. A separate meta-analysis in the Journal of Global Antimicrobial Resistance tracked clindamycin resistance climbing from roughly 25% before 2015 to over 35% in recent years. If the dominant bacteria on your skin have already adapted to the drug you're taking, the prescription has little to work with.

The antibiotic may be treating the wrong organism entirely. Acne, folliculitis, HS, and undiagnosed inflammatory flares can involve overlapping but different bacterial communities, including Staphylococcus aureus, Staphylococcus epidermidis, and anaerobic species like Prevotella and Finegoldia. Research on HS lesions has repeatedly found that the bacteria driving inflammation vary from patient to patient and even from lesion to lesion. A standard prescription is a generalized guess, not a personalized match.

Biofilms let bacteria hide. Many skin bacteria can form protective biofilm structures that shield them from antibiotics that would otherwise work, which is part of why relapse after "successful" treatment is so common.

And sometimes bacteria aren't the driver at all. A condition that looks exactly like acne, especially small, itchy, uniform bumps on the chest, back, or shoulders, can actually be Malassezia folliculitis, a yeast overgrowth that a 2025 review in the Journal of Fungi found is frequently misdiagnosed as acne vulgaris and often worsens with antibiotics, since antibiotics clear out competing bacteria and give the yeast more room to grow. Persistent lesions or flares can also stem from viral triggers or from an immune system that is driving inflammation largely on its own, independent of any single overgrown microbe. None of these respond to an antibiotic, no matter how well matched or how long the course.

And there's a real cost to staying on antibiotics that aren't working. Extended courses are linked to gut microbiome disruption, yeast overgrowth, GI upset, photosensitivity, and in the case of long-term tetracyclines, rare but serious risks. Taking a drug that isn't clearing the underlying bacteria means absorbing those side effects for little or no benefit, while the bacteria you're trying to treat build further resistance.

You Can't Treat What You Haven't Measured - Skin Microbiome Testing

Most antibiotic prescriptions for skin conditions are written without ever sequencing what's actually living on the skin. Parallel Health's approach starts there. Skin microbiome testing uses quantitative whole-genome shotgun metagenomic sequencing, sampled from the face, a specific body spot, an odor-affected area, or the scalp, to identify every microorganism present, how abundant each one is, and what those microbes are metabolically doing, not just their names. The result is a Quantitative Microbial Analysis™ paired with a Metabolic Microbiome Profiling™, and because the test reads the full microbial picture rather than assuming bacteria are the cause, it can also surface fungal overgrowth like Malassezia or flag that the microbial picture looks essentially normal. When the ecosystem is not driving the flare, that finding rules out a microbial root and points your provider toward immune-focused support instead of another round of antibiotics.

Your Antibiotic Resistance Score: Reading Your Bacteria's DNA

Because the test reads bacterial DNA directly, it can also identify known resistance genes carried by the organisms overgrowing on your skin. That produces an antibiotic resistance score: a data-driven indication of whether a given antibiotic class is likely to work against your specific bacterial population, before you take it, or after a prior course has failed. This turns prescribing from trial and error into an informed decision grounded in your own microbial data.

Phage Therapy as a Targeted Alternative, Especially in Circumstances of Antibiotic Resistance

Parallel Health formulates custom phage serums for patients regardless of their antibiotic resistance score, because the approach is sustainable, gentle on the rest of the skin's ecosystem, and effective at the strain level. Each formula uses precision-targeted nano-microbes bred to seek out and knock back the specific bacterial strain the sequencing identified, without disrupting the surrounding microbial community the way broad-spectrum antibiotics do.

That precision matters most when resistance is high. For a strain that's already resistant to the antibiotics that would normally be tried, phage therapy is one of the few remaining options that can still target it directly, rather than cycling through additional antibiotic classes and risking the same resistance and side-effect problems all over again. It's not a fallback guess. It's an option built directly off what the sequencing already found.

FAQ

Can antibiotic resistance really explain why my skin isn't improving? Yes. Published resistance surveillance shows a substantial share of the bacteria involved in acne, folliculitis, HS, and other inflammatory issues carry resistance genes against commonly prescribed antibiotics, particularly clindamycin and macrolides.

How is skin microbiome testing different from a standard skin culture? A culture typically identifies one suspected organism using older lab methods. Quantitative whole-genome shotgun metagenomic sequencing profiles the entire microbial community at once, including abundance and metabolic activity, along with resistance genes.

Is phage therapy safe? Clinical reviews of bacteriophage use in skin and soft tissue infections describe high specificity for target bacteria and an extremely favorable safety profile compared to broad-spectrum antibiotics, though phage therapy in the U.S. is still an emerging, compounded, physician-directed treatment rather than an FDA-approved drug class.

Do I need a new prescription to get tested? No, you do not need a prescription to get tested. You can order a test directly through Parallel Health with or without a clinical protocol. Without a protocol, you can order testing à la carte. However, when you sign up for the MD-03 Protocol™, a test automatically comes to you in the first month and every 6 active months after.

My teenager's acne keeps coming back despite multiple rounds of antibiotics, and the next step being discussed is Accutane. Are there other options worth trying first?
Yes. Phage therapy is a real alternative for patients, including teens, who want to avoid the side effects of isotretinoin (Accutane), and it starts with testing to see what's actually overgrowing on the skin, so the phage recommended is matched to the strain causing the breakouts rather than a guess. Because a phage targets one bacterial species instead of broadly disrupting the skin, or the whole body the way isotretinoin does, published safety data describe it as one of the gentler options available, with high specificity for the target bacteria and low side-effect rates compared to systemic drugs. That doesn't make it automatically the right call for every case of severe, scarring acne, but it's worth raising alongside Accu

What if my flare isn't caused by bacteria at all? Sequencing can identify non-bacterial drivers like fungi, or show that the microbial community looks unremarkable, which points toward a viral or immune-driven process instead. Either way, you get a clearer answer than another antibiotic trial.

References

1. Zhu C, Wei B, Li Y, Wang C. "Antibiotic resistance rates in Cutibacterium acnes isolated from patients with acne vulgaris: a systematic review and meta-analysis." Frontiers in Microbiology, 2025. DOI: 10.3389/fmicb.2025.1565111
2. Beig M, Shirazi O, Ebrahimi E, Zare Banadkouki A, Golab N, Sholeh M. "Prevalence of antibiotic-resistant Cutibacterium acnes (formerly Propionibacterium acnes) isolates: a systematic review and meta-analysis." Journal of Global Antimicrobial Resistance, 2024;39:82-91.
3. "Unraveling the Skin Microbiome in Hidradenitis Suppurativa: Implications for Treatment and Disease Progression." PMC, 2025. https://pmc.ncbi.nlm.nih.gov/articles/PMC11989415/
4. "The Skin Microbiome in Hidradenitis Suppurativa: Pathogenic Insights, Therapeutic Implications, and Future Directions." Venereology (MDPI), 2026. https://www.mdpi.com/2673-6179/6/2/15
5. "Genome-Based Prediction of Bacterial Antibiotic Resistance." Journal of Clinical Microbiology, 2019. DOI: 10.1128/jcm.01405-18
6. "Bacteriophages in the treatment of cutaneous infections and skin disorders: therapeutic advances and future directions." Clinical Microbiology Reviews, 2026. DOI: 10.1128/cmr.00048-26
7. "Malassezia Folliculitis: An Underdiagnosed Mimicker of Acneiform Eruptions." Journal of Fungi (MDPI), 2025. https://www.mdpi.com/2309-608X/11/9/662
8. "Innate immunity and microbial dysbiosis in hidradenitis suppurativa, vicious cycle of chronic inflammation." Frontiers in Immunology, 2022. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9368759/